• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Atlantic International Corp.

    7/7/25 12:15:24 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: July 3, 2025 4:00 P.M.
    Form: S-3
    CIK: 0001605888
    Company Name: ATLANTIC INTERNATIONAL CORP.
    File Number: 333-288226
    Get the next $ATLN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:11:34 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:04:40 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:02:59 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Atlantic International Corp.

    SCHEDULE 13D/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Subject)

    8/15/25 4:05:06 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form RW filed by Atlantic International Corp.

    RW - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    7/14/25 4:05:04 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 424B3 filed by Atlantic International Corp.

    424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    7/8/25 4:31:45 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Broderick Christopher

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/15/25 5:10:50 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by General Counsel Tenore Michael

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/13/25 4:46:32 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Executive Officer Jagid Jeffrey M gifted 400,000 shares, decreasing direct ownership by 11% to 3,335,169 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/13/25 4:45:41 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Corp. to Present at the 2025 Gateway Conference on September 4

    ENGLEWOOD CLIFFS, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a rapidly expanding provider of workforce solutions and outsourced services, today announced that its CEO will present at the 2025 Annual Gateway Conference, one of the nation's premier investor events connecting high-growth companies with institutional investors, analysts, and capital markets professionals. The conference will take place September 4–5, 2025, at the Four Seasons Hotel in San Francisco, CA. Jeffrey Jagid, Atlantic International Corp.'s CEO, is scheduled to present on Thursday, September 4 at 9:00 a.m. Pacific Time (PT). The presentation will be webcast live and ava

    8/18/25 7:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Reports Strong Operational Improvements in Second Quarter 2025

    ENGLEWOOD CLIFFS, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading strategic staffing, outsourced services, and workforce solutions company, today announced financial results for the second quarter ended June 30, 2025, demonstrating significant operational improvements and a strengthened financial position. Second Quarter 2025 Highlights: Net loss narrowed by 81% to $10.7 million (or $0.20 per share), compared to a net loss of $54.9 million (or $1.96 per share) in Q2 2024Service revenue was $102.9 million, with permanent placement services up 17% year-over-year.Gross profit margin improved to 11.1%, reflecting pricing discipline and efficiency

    8/14/25 7:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gateway Group Announces Preliminary Sponsors and Presenting Companies for 2025 Gateway Conference

    NEWPORT BEACH, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Gateway Group ("Gateway"), a leading financial communications and digital media advisory firm, today announced the initial sponsors and presenting companies confirmed for its annual Gateway Conference taking place at the Four Seasons Hotel in San Francisco on September 3rd and 4th. The conference is expected to host more than 300 institutional investors and analysts for two days of company presentations and curated one-on-one meetings with executives from high-growth public and private companies across the tech, AI, cleantech, consumer, financial services, and industrials sectors. "We appreciate the strong support from our sponsors

    7/30/25 8:30:00 AM ET
    $ACNT
    $AIRG
    $AKA
    Steel/Iron Ore
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ATLN
    Leadership Updates

    Live Leadership Updates

    View All

    Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

    ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

    6/2/25 1:05:49 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Financials

    Live finance-specific insights

    View All

    Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

    Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

    3/28/25 7:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials